[Wang, Jin; Hu, Haoliang] Institute of Pharmacy and Pharmacology, Learning Key Laboratory for Pharmacoproteomics, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science, Hengyang Medical College, University of South China, Hengyang 421001, China

[Jiang, Jinyong] Department of Pharmacy, The First Affiliated Hospital of Jishou University, Jishou 416000, China

[Hu, Haoliang] College of Medicine, Hunan University of Arts and Science, Changde 415000, China. Electronic address: huhl@huas.edu.cn

[Chen, Linxi] Institute of Pharmacy and Pharmacology, Learning Key Laboratory for Pharmacoproteomics, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science, Hengyang Medical College, University of South China, Hengyang 421001, China. Electronic address: 1995001765@usc.edu.cn

[Haoliang Hu; Linxi Chen] I

Institute of Pharmacy and Pharmacology, Learning Key Laboratory for Pharmacoproteomics, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science, Hengyang Medical College, University of South China, Hengyang 421001, China<&wdkj&>College of Medicine, Hunan University of Arts and Science, Changde 415000, China<&wdkj&>Institute of Pharmacy and Pharmacology, Learning Key Laboratory for Pharmacoproteomics, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science, Hengyang Medical College, University of South China, Hengyang 421001, China

Cell behavior;Human diseases;MCU;Mitochondrial dynamics;Mitochondrial pathophysiology;Potential targets

药学与生物科学学院